This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rittichier, K. K.
Right arrow Articles by Ledwith, C. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rittichier, K. K.
Right arrow Articles by Ledwith, C. A.
Related Collections
Right arrow Infectious Disease & Immunity

PEDIATRICS Vol. 106 No. 6 December 2000, pp. 1344-1348

Outpatient Treatment of Moderate Croup With Dexamethasone: Intramuscular Versus Oral Dosing

Received Jan 14, 2000; accepted May 9, 2000.

Kristine K. Rittichier and Carol A. LedwithDagger

From the Primary Children's Medical Center, University of Utah, Salt Lake City, Utah; and Dagger  Children's Hospital, University of Colorado Health Sciences Center, Denver, Colorado.

Objective.  Steroid use for the treatment of croup has been supported by several studies, although few have addressed the use of oral dexamethasone for outpatient management. The efficacy of oral (PO) versus intramuscular (IM) dosing of dexamethasone in the outpatient treatment of moderate croup are compared in this study.

Methods.  Patients between the ages of 3 months and 12 years with moderate croup (history or presence of stridor, cyanosis, or retractions) were eligible for enrollment in this single-blind, prospective study. Patients were randomized to receive a single dose (0.6 mg/kg, maximum 8 mg) of IM or PO dexamethasone. Parents were contacted by phone to assess resolution of symptoms and need for further evaluation.

Results.  Two hundred seventy-seven patients were enrolled (median age: 2.1 years). One hundred thirty-nine patients received IM dexamethasone, and 138 received PO. At phone follow-up, 141 (51%) had total resolution of symptoms (75 in IM, 66 in PO). Eighty patients (29%) returned for further evaluation (45 in IM, 35 in PO). Twenty-three (8%) received either more steroids, racemic epinephrine, or admission (11 in IM, 12 in PO).

Conclusion.  No statistically significant difference was found in the need for subsequent interventions after a single dose of either IM or PO dexamethasone. A single PO dose of dexamethasone can be effectively and safely used for the outpatient treatment of moderate croup.  Key words:  croup, dexamethasone, laryngotracheobronchitis, pediatrics.




This article has been cited by other articles:


Home page
 Emerg. Med. J.Home page
C Vorwerk and T J Coats
Use of helium-oxygen mixtures in the treatment of croup: a systematic review
Emerg. Med. J., September 1, 2008; 25(9): 547 - 550.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child.Home page
A Sparrow and G Geelhoed
Prednisolone versus dexamethasone in croup: a randomised equivalence trial
Arch. Dis. Child., July 1, 2006; 91(7): 580 - 583.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
A. O. Segal, E. J. Crighton, R. Moineddin, M. Mamdani, and R. E.G. Upshur
Croup Hospitalizations in Ontario: A 14-Year Time-Series Analysis
Pediatrics, July 1, 2005; 116(1): 51 - 55.
[Abstract] [Full Text] [PDF]

Home page
 Evid. Based Nurs.Home page
A. Twycross
Oral dosing of dexamethasone was as effective as intramuscular dosing for outpatient treatment of children with moderate croup
Evid. Based Nurs., July 1, 2001; 4(3): 79 - 79.
[Full Text] [PDF]

Home page
 JWatch GeneralHome page
Steroids for Croup: Intramuscular or Oral?
Journal Watch (General), December 22, 2000; 2000(1222): 5 - 5.
[Full Text]